Space-Based Biopharmaceuticals Global Market Report 2025
상품코드:1760718
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
우주 기반 바이오의약품 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년에는 11.7%의 연평균 복합 성장률(CAGR)로 74억 6,000만 달러에 달할 것으로 예측됩니다. 예측 기간의 성장은 상업용 우주 산업의 확대, 우주 관광의 부상, 세계 인구의 고령화, 맞춤형 의료에 대한 수요 증가, 우주 연구에 대한 투자 증가에 의해 주도될 것으로 예측됩니다. 예측 기간의 주요 동향으로는 원격 생물학적 제제 제조, AI 기반 실험 설계, 원격 의료와 우주 연구의 통합, 분석 장비의 소형화, 자동 우주 실험 플랫폼의 개발 등이 있습니다.
첨단 치료제에 대한 수요 증가는 우주 기반 바이오 의약품 시장의 성장을 가속할 것으로 예측됩니다. 유전자 치료, 세포 치료, 생물학적 제제를 포함한 이러한 차세대 치료제는 분자 또는 세포 수준에서 질병을 표적으로 삼는 것을 목표로 합니다. 암, 유전성 질환, 자가면역질환과 같은 복잡하고 만성적인 질환의 유병률이 증가함에 따라 기존 방식보다 더 개인화되고 표적화된 효과적인 치료법이 요구되면서 수요가 증가하고 있습니다. 우주 기반 바이오의약품은 미세중력이라는 독특한 환경을 이용하여 약효를 향상시키고 복잡한 생물학적 제제의 생산 속도를 높임으로써 이러한 수요를 충족시키는 데 일조할 수 있습니다. 예를 들어, 2023년 12월 영국의 첨단 치료 센터는 2021년에서 2022년 사이에 첨단 치료에 대한 투자가 31% 증가했다고 보고했습니다. 이러한 추세는 첨단 치료제에 대한 수요 증가가 우주 기반 바이오 의약품 시장의 확대를 촉진하고 있음을 보여줍니다.
우주 기반 바이오 의약품 시장의 기업들은 첨단 기술을 통합하기 위해 전략적 제휴를 맺는 경우가 증가하고 있습니다. 이러한 제휴는 LIFE Pathfinder 모듈에 첨단 바이오 의약품 및 제조 시설을 제공하는 데 초점을 맞추고 있으며, 바이오 의약품 연구 및 제조의 엄격한 기준을 충족하도록 설계되었습니다. 예를 들어, 2023년 8월 미국의 상업용 우주 기업 시에라 스페이스(Sierra Space)는 레드와이어(Redwire)와 파트너십을 맺고 저궤도(LEO)에서의 상업용 제약 및 생명공학 연구 역량을 개발했습니다. 이번 제휴에는 시에라스페이스의 LIFE Habitat 플랫폼에 통합될 첨단 생명공학 및 제조 기술 제공이 포함됩니다. 이 기술에는 고분자 결정화 장비, 산업용 결정 제조 장비, 온도 구배로 등이 포함되며, 모두 미세중력 하에서 의약품 개발 및 인체 건강 연구를 지원하는 것을 목표로 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 우주 기반 바이오의약품 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 우주 기반 바이오의약품 시장 : 성장률 분석
세계의 우주 기반 바이오의약품 시장 실적 : 규모와 성장, 2019-2024
세계의 우주 기반 바이오의약품 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 우주 기반 바이오의약품 전체 시장(TAM)
제6장 시장 세분화
세계의 우주 기반 바이오의약품 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
백신
치료제
진단
기타 제품 유형
세계의 우주 기반 바이오의약품 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
암 치료
감염증
유전성 질환
기타 용도
세계의 우주 기반 바이오의약품 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제약회사
연구기관
의료 제공자
기타 최종사용자
세계의 우주 기반 바이오의약품 시장 : 백신 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
감염증 백신
암백신
RNA 기반 백신
치료 백신
예방 백신
세계의 우주 기반 바이오의약품 시장 : 치료제 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
단일클론항체
유전자 치료
세포치료
단백질 기반 치료법
펩티드 기반 치료법
세계의 우주 기반 바이오의약품 시장 : 진단별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
분자진단
면역측정
POC(Point of Care) 진단
바이오마커 발견
체외진단
세계의 우주 기반 바이오의약품 시장 : 기타 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
재생의료
생물학적 제제
조직공학 제품
생화학 시약
우주 연구용 실험 소모품
제7장 지역별/국가별 분석
세계의 우주 기반 바이오의약품 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 우주 기반 바이오의약품 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
우주 기반 바이오의약품 시장 : 경쟁 구도
우주 기반 바이오의약품 시장 : 기업 개요
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Sierra Space Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Rocket Lab USA Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Redwire Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Axiom Space Inc.
Varda Space Industries Inc.
Nanoracks LLC
ResearchSat Pty Ltd.
Techshot Inc.
Space Tango Inc.
nScrypt Inc.
SpacePharma SA
Space Forge Ltd.
LambdaVision Inc.
Kibo Biotech Platform
ISS National Lab
BioServe Space Technologies
Space LiinTech
BioOrbit
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
우주 기반 바이오의약품 시장(2029년) : 새로운 기회를 제공하는 국가
우주 기반 바이오의약품 시장(2029년) : 새로운 기회를 제공하는 부문
우주 기반 바이오의약품 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Space-based biopharmaceuticals are drugs and biologics that are developed or produced in the unique conditions of space, especially microgravity. These conditions can improve processes such as protein crystallization and drug stability. The goal is to use space's environment to create more effective treatments and innovative compounds that may not be possible to develop on Earth.
The primary categories of space-based biopharmaceuticals include vaccines, therapeutics, diagnostics, and other related products. Research conducted in space helps create vaccines that are more stable and effective by utilizing microgravity to improve antigen stability, protein crystallization, and immune response modeling. These products are applied in areas such as cancer treatment, infectious diseases, genetic disorders, and various other health conditions. The main users of these products include pharmaceutical companies, research organizations, healthcare providers, and additional stakeholders.
The space-based biopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides space-based biopharmaceuticals market statistics, including the space-based biopharmaceuticals industry global market size, regional shares, competitors with the space-based biopharmaceuticals market share, detailed space-based biopharmaceuticals market segments, market trends, and opportunities, and any further data you may need to thrive in the space-based biopharmaceuticals industry. This space-based biopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The space-based biopharmaceuticals market size has grown rapidly in recent years. It will grow from $4.29 billion in 2024 to $4.80 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth observed during the historic period can be credited to the rising demand for high-quality biopharmaceuticals, the emergence of private companies in the space sector, increased financial investment in space missions, the development and functionality of space stations, and the expansion of space-based manufacturing.
The space-based biopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $7.46 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period is expected to be driven by the expansion of the commercial space industry, the rise of space tourism, the aging global population, the growing demand for personalized medicine, and increased investment in space research. Key trends for the forecast period include remote biologics manufacturing, AI-driven experiment design, integration of telemedicine with space research, miniaturization of analytical devices, and the development of automated space lab platforms.
The increasing demand for advanced therapeutics is expected to drive the growth of the space-based biopharmaceuticals market. These next-generation treatments, including gene therapy, cell therapy, and biologics, aim to target diseases at the molecular or cellular level. The rising demand is fueled by the growing prevalence of complex and chronic conditions such as cancer, genetic disorders, and autoimmune diseases, which require more personalized, targeted, and effective therapies than traditional methods offer. Space-based biopharmaceuticals help meet this demand by using the unique environment of microgravity to improve drug efficacy and speed up the production of complex biologics. For example, in December 2023, the Advanced Therapy Treatment Centre in the UK reported a 31% increase in investment in advanced therapies between 2021 and 2022. This trend demonstrates how the growing demand for advanced therapeutics is driving the expansion of the space-based biopharmaceuticals market.
Companies in the space-based biopharmaceuticals market are increasingly forming strategic alliances to integrate cutting-edge technology. These collaborations focus on providing advanced biopharma and manufacturing facilities for the LIFE Pathfinder module, which are designed to meet the rigorous standards of biopharmaceutical research and production. For example, in August 2023, Sierra Space, a US-based commercial space company, partnered with Redwire Corporation to develop commercial pharmaceutical and biotech research capabilities in low-Earth orbit (LEO). This partnership also involves providing advanced biotechnology and manufacturing technologies to be incorporated into Sierra Space's LIFE habitat platform. The technologies include equipment for large molecule crystallization, industrial crystal manufacturing, and gradient-temperature furnaces, all aimed at supporting pharmaceutical drug development and human health research in microgravity.
In March 2025, Sierra Space joined forces with Yuri, a Germany-based space biotech company specializing in microgravity research and bioreactor technology. The goal of this partnership is to accelerate medical and biological research in space, facilitating innovative drug discovery and the development of advanced therapeutic solutions for diseases on Earth.
Major players in the space-based biopharmaceuticals market are Merck & Co. Inc., Bristol-Myers Squibb Company, Sierra Space Corporation, Rocket Lab USA Inc., Redwire Corporation, Axiom Space Inc., Varda Space Industries Inc., Nanoracks LLC, ResearchSat Pty Ltd., Techshot Inc., Space Tango Inc., nScrypt Inc., SpacePharma SA, Space Forge Ltd., LambdaVision Inc., Kibo Biotech Platform, ISS National Lab, BioServe Space Technologies, Space LiinTech, BioOrbit.
North America was the largest region in the space-based biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in space-based biopharmaceuticals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the space-based biopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The space-based biopharmaceuticals market consists of revenues earned by entities by providing services such as microgravity research, in-space manufacturing, ISS utilization, and biocrystal optimization services. The market value includes the value of related goods sold by the service provider or included within the service offering. The space-based biopharmaceuticals market also consists of sales of products including protein crystals for drug development, artificial retinas, stem cell-based therapies, and drug delivery systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Space-Based Biopharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on space-based biopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for space-based biopharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The space-based biopharmaceuticals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Vaccines; Therapeutics; Diagnostics; Other Product Types
2) By Application: Cancer Treatment; Infectious Diseases; Genetic Disorders; Other Applications
3) By End-User: Pharmaceutical Companies; Research Institutes; Healthcare Providers; Other End Users
Subsegment:
1) By Vaccines: Infectious Disease Vaccines; Cancer Vaccines; RNA-Based Vaccines; Therapeutic Vaccines; Preventive Vaccines
3) By Diagnostics: Molecular Diagnostics; Immunoassays; Point-of-Care Diagnostics; Biomarker Discovery; In Vitro Diagnostics
4) By Other Product Types: Regenerative Medicines; Biologics; Tissue Engineering Products; Bio-Chemical Reagents; Laboratory Consumables for Space Research
Companies Mentioned: Merck & Co. Inc.; Bristol-Myers Squibb Company; Sierra Space Corporation; Rocket Lab USA Inc.; Redwire Corporation
3. Space-Based Biopharmaceuticals Market Trends And Strategies
4. Space-Based Biopharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Space-Based Biopharmaceuticals Growth Analysis And Strategic Analysis Framework
5.1. Global Space-Based Biopharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Space-Based Biopharmaceuticals Market Growth Rate Analysis
5.4. Global Space-Based Biopharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Space-Based Biopharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Space-Based Biopharmaceuticals Total Addressable Market (TAM)
6.1. Global Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vaccines
Therapeutics
Diagnostics
Other Product Types
6.2. Global Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Treatment
Infectious Diseases
Genetic Disorders
Other Applications
6.3. Global Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Research Institutes
Healthcare Providers
Other End Users
6.4. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Disease Vaccines
Cancer Vaccines
RNA-Based Vaccines
Therapeutic Vaccines
Preventive Vaccines
6.5. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Gene Therapies
Cell Therapies
Protein-Based Therapies
Peptide-Based Therapies
6.6. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Molecular Diagnostics
Immunoassays
Point-of-Care Diagnostics
Biomarker Discovery
In Vitro Diagnostics
6.7. Global Space-Based Biopharmaceuticals Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Regenerative Medicines
Biologics
Tissue Engineering Products
Bio-Chemical Reagents
Laboratory Consumables for Space Research
7. Space-Based Biopharmaceuticals Market Regional And Country Analysis
7.1. Global Space-Based Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Space-Based Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Space-Based Biopharmaceuticals Market
9.1. China Space-Based Biopharmaceuticals Market Overview
9.2. China Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Space-Based Biopharmaceuticals Market
10.1. India Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Space-Based Biopharmaceuticals Market
11.1. Japan Space-Based Biopharmaceuticals Market Overview
11.2. Japan Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Space-Based Biopharmaceuticals Market
12.1. Australia Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Space-Based Biopharmaceuticals Market
13.1. Indonesia Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Space-Based Biopharmaceuticals Market
14.1. South Korea Space-Based Biopharmaceuticals Market Overview
14.2. South Korea Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Space-Based Biopharmaceuticals Market
15.1. Western Europe Space-Based Biopharmaceuticals Market Overview
15.2. Western Europe Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Space-Based Biopharmaceuticals Market
16.1. UK Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Space-Based Biopharmaceuticals Market
17.1. Germany Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Space-Based Biopharmaceuticals Market
18.1. France Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Space-Based Biopharmaceuticals Market
19.1. Italy Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Space-Based Biopharmaceuticals Market
20.1. Spain Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Space-Based Biopharmaceuticals Market
21.1. Eastern Europe Space-Based Biopharmaceuticals Market Overview
21.2. Eastern Europe Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Space-Based Biopharmaceuticals Market
22.1. Russia Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Space-Based Biopharmaceuticals Market
23.1. North America Space-Based Biopharmaceuticals Market Overview
23.2. North America Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Space-Based Biopharmaceuticals Market
24.1. USA Space-Based Biopharmaceuticals Market Overview
24.2. USA Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Space-Based Biopharmaceuticals Market
26.1. South America Space-Based Biopharmaceuticals Market Overview
26.2. South America Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Space-Based Biopharmaceuticals Market
27.1. Brazil Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Space-Based Biopharmaceuticals Market
28.1. Middle East Space-Based Biopharmaceuticals Market Overview
28.2. Middle East Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Space-Based Biopharmaceuticals Market
29.1. Africa Space-Based Biopharmaceuticals Market Overview
29.2. Africa Space-Based Biopharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Space-Based Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Space-Based Biopharmaceuticals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Space-Based Biopharmaceuticals Market Competitive Landscape And Company Profiles
